A carregar...
Understanding the FOLFOXIRI-regimen to optimize treatment for metastatic colorectal cancer
The management of metastatic colorectal cancer substantially improved over the last 10 years and median overall survival of patients might exceed 30 months. The selection of an effective first-line treatment represents a crucial point in order to achieve good outcome results. In the last years, the...
Na minha lista:
| Publicado no: | Crit Rev Oncol Hematol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4799732/ https://ncbi.nlm.nih.gov/pubmed/26850575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.critrevonc.2016.01.020 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|